Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trial

BACKGROUND: This exploratory study investigated four repurposed anti-infective drug regimens in outpatients with COVID-19. METHODS: This phase 2, single centre, randomised, open-label, clinical trial was conducted in South Africa between 3rd September 2020 and 23rd August 2021. Symptomatic outpatien...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandiwana, Nomathemba, Kruger, Chelsea, Johnstone, Hilary, Chughlay, Mohamed Farouk, Ju, Chung, Kim, Byungsu, Dineka, Yengiwe, Arbe-Barnes, Sarah, Miller, Robert, Owen, Andrew, Hill, Andrew, Windgassen, Daniel, Abla, Nada, Marrast, Anne Claire, Duparc, Stephan, Francois Venter, Willem Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624152/
https://www.ncbi.nlm.nih.gov/pubmed/36332361
http://dx.doi.org/10.1016/j.ebiom.2022.104322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624152/
https://www.ncbi.nlm.nih.gov/pubmed/36332361
http://dx.doi.org/10.1016/j.ebiom.2022.104322

Ejemplares similares